This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1JW Yuen & MD Gohel (2005) Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 53, 11–17.
2B Boh , M Berovic , J Zhang , (2007) Ganoderma lucidum and its pharmaceutically active compounds. Biotechnol Annu Rev 13, 265–301.
3MS Shiao (2003) Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions. Chem Rec 3, 172–180.
4Y Komoda , M Shimizu , Y Sonoda , (1989) Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem Pharm Bull (Tokyo) 37, 531–533.
5SY Lee & HM Rhee (1990) Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem Pharm Bull (Tokyo) 38, 1359–1364.
6JM Lee , H Kwon , H Jeong , (2001) Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res 15, 245–249.
7M Zhu , Q Chang , LK Wong , (1999) Triterpene antioxidants from Ganoderma lucidum. Phytother Res 13, 529–531.
8KN Lai , LY Chan , SC Tang , (2006) Ganoderma extract prevents albumin-induced oxidative damage and chemokines synthesis in cultured human proximal tubular epithelial cells. Nephrol Dial Transplant 21, 1188–1197.
9H Hikino , C Konno , Y Mirin , (1985) Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies 1. Planta Med 51, 339–340.
11SW Seto , TY Lam , HL Tam , (2009) Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine 16, 426–436.
12S Wachtel-Galor , YT Szeto , B Tomlinson , (2004) Ganoderma lucidum (‘Lingzhi’); acute and short-term biomarker response to supplementation. Int J Food Sci Nutr 55, 75–83.
14PM Stewart (2003) Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action. Eur J Endocrinol 149, 163–168.
16GY Csabi , S Juricskay & D Molnar (2000) Urinary cortisol to cortisone metabolites in hypertensive obese children. J Endocrinol Invest 23, 435–439.
17SH van Uum , JW Lenders & AR Hermus (2004) Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension. Semin Vasc Med 4, 121–128.
18IF Benzie & JJ Strain (1996) The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay. Anal Biochem 239, 70–76.
20DI Thurnham , JA Davies , BJ Crump , (1986) The use of different lipids to express serum tocopherol:lipid ratios for the measurement of vitamin E status. Ann Clin Biochem 23, 514–520.
22SL Schwartz (2006) Diabetes and dyslipidaemia. Diabetes Obes Metab 8, 355–364.
23K Kobayashi , TM Forte , S Taniguchi , (2000) The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 49, 22–31.
24J de Vries-van der Weij , S Zadelaar , K Toet , (2009) Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice. Atherosclerosis 206, 153–158.
25PS MacLean , JF Bower , S Vadlamudi , (2003) Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db/db mice. Arterioscler Thromb Vasc Biol 23, 1412–1415.
26LS Tam , B Tomlinson , TT Chu , (2007) Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 26, 1495–1498.
27A Tchernof , B Lamarche , D Prud'Homme , (1996) The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 19, 629–637.
28SY Wang , ML Hsu , HC Hsu , (1997) The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 70, 699–705.
29EK Li , LS Tam , CK Wong , (2007) Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial. Arthritis Rheum 57, 1143–1150.
30Y Xi Bao , C Kwok Wong , E Kwok Ming Li , (2006) Immunomodulatory effects of lingzhi and san-miao-san supplementation on patients with rheumatoid arthritis. Immunopharmacol Immunotoxicol 28, 197–200.
31FF Lam , IW Ko , ES Ng , (2008) Analgesic and anti-arthritic effects of Lingzhi and San Miao San supplementation in a rat model of arthritis induced by Freund's complete adjuvant. J Ethnopharmacol 120, 44–50.
32SM Wicks , R Tong , CZ Wang , (2007) Safety and tolerability of Ganoderma lucidum in healthy subjects: a double-blind randomized placebo-controlled trial. Am J Chin Med 35, 407–414.
33D Armanini , C Fiore , MJ Mattarello , (2002) History of the endocrine effects of licorice. Exp Clin Endocrinol Diabetes 110, 257–261.
34HA Sigurjonsdottir , K Manhem , M Axelson , (2003) Subjects with essential hypertension are more sensitive to the inhibition of 11 beta-HSD by liquorice. J Hum Hypertens 17, 125–131.